IH

iHuman Inc. [IH] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

IH Stock Summary

Top 10 Correlated ETFs

IH


Top 10 Correlated Stocks

IH


In the News

12:34 10 Jun 2023 IH

iHuman Clocks 105% Growth In Q2 Revenue

iHuman Inc (NYSE: IH) reported second-quarter FY21 revenue growth of 105.9% year-on-year, to RMB221.3 million ($34.3 million). Revenues from online subscriptions rose 110.1% Y/Y to RMB199.2 million ($30.9 million).

07:48 10 Jun 2023 IH

iHuman Inc. Announces Second Quarter 2021 Unaudited Financial Results

BEIJING, Sept. 29, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered smart learning products in China, today announced its unaudited financial results for the second quarter ended June 30, 2021.

01:18 10 Jun 2023 IH

iHuman Inc. (IH) CEO Dr. Peng Dai on Q1 2021 Results - Earnings Call Transcript

iHuman Inc. (IH) CEO Dr. Peng Dai on Q1 2021 Results - Earnings Call Transcript

01:47 10 Jun 2023 IH

iHuman Inc. Announces First Quarter 2021 Unaudited Financial Results

BEIJING, June 8, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("Human" or the "Company"), a leading childhood edutainment company in China, today announced its unaudited financial results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights Total revenues were RMB226.7 million (US$34.6 million), a year-over-year increase of 190.6%.

03:19 10 Jun 2023 IH

iHuman Inc. to Report First Quarter 2021 Unaudited Financial Results on June 8, 2021

BEIJING, June 3, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading childhood edutainment company in China, announced today that it will report its unaudited financial results for the first quarter ended March 31, 2021, before U.S. markets open on June 8, 2021. The Company's management will hold an earnings conference call on Tuesday, June 8, 2021 at 8:00 a.m.

04:23 10 Jun 2023 IH

iHuman Inc. Files 2020 Annual Report on Form 20-F

BEIJING, China, April 28, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading childhood edutainment company in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission on April 28, 2021. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/.

01:11 10 Jun 2023 IH

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results

BEIJING, March 25, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading childhood edutainment company in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020. Fourth Quarter 2020 Highlights Total revenues were RMB189.5 million (US$29.0 million), a year-over-year increase of 206.4%.

06:00 10 Jun 2023 IH

iHuman Inc. to Report Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results on March 25, 2021

BEIJING, March 19, 2021 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading childhood edutainment company in China, announced today that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020, before U.S. markets open on March 25, 2021. The Company's management will hold an earnings conference call on Thursday, March 25, 2021 at 8:00 a.m.

02:16 10 Jun 2023 IH

iHuman: Clear Leader In Child Edutainment In China

iHuman became #1 in the market in 4 years with no marketing spend purely because of its superior product quality. Substantial number of revenue growth drivers including capturing market share, new product launches, and international expansion.

IH Financial details

Company Rating
Strong Buy
Market Cap
153.59M
Income
109.82M
Revenue
985.52M
Book val./share
14.46
Cash/share
19.73
Dividend
-
Dividend %
-
Employees
770
Optionable
No
Shortable
Yes
Earnings
19 Jun 2023
P/E
9.98
Forward P/E
-
PEG
-0.25
P/S
1.11
P/B
1.42
P/C
0.15
P/FCF
5.85
Quick Ratio
2.02
Current Ratio
2.23
Debt / Equity
0.01
LT Debt / Equity
0
-
-
EPS (TTM)
2.07
EPS next Y
-
EPS next Q
-
EPS this Y
-99.97%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-78.01%
Revenue last 5Y
49.52%
Revenue Q/Q
3.65%
EPS Q/Q
-9.46%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-25%
Inst Own
0.97%
Inst Trans
-0.02%
ROA
8%
ROE
16%
ROC
0.15%
Gross Margin
70%
Oper. Margin
12%
Profit Margin
11%
Payout
2%
Shs Outstand
53.14M
Shs Float
16.04M
-
-
-
-
Target Price
-
52W Range
1.34-4.26
52W High
-26%
52W Low
+196%
RSI
42
Rel Volume
0.81
Avg Volume
12.06K
Volume
9.8K
Perf Week
13.41%
Perf Month
-6.6%
Perf Quarter
28.14%
Perf Half Y
52.58%
-
-
-
-
Beta
0.237106
-
-
Volatility
0.09%, 0.37%
Prev Close
6.86%
Price
2.96
Change
8.42%

IH Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
2.914.8311.7517.720
Net income per share
-0.39-6.09-0.83-0.690
Operating cash flow per share
-0.10.944.930.720
Free cash flow per share
-0.110.894.570.110
Cash per share
0.142.3219.0416.040
Book value per share
-1.41-0.3214.211.410
Tangible book value per share
-1.41-0.3213.9410.90
Share holders equity per share
-1.41-0.3214.211.410
Interest debt per share
0-0.1-0.080.320
Market cap
4.98B5.05B5.35B951.44M4058.82B
Enterprise value
4.98B4.94B4.49B130.33M4057.78B
P/E ratio
-283.02-18.31-142.75-25.6836.96K
Price to sales ratio
37.7823.0810.061.014.12K
POCF ratio
-1.11K118.3723.9924.921.54K
PFCF ratio
-989.91125.4125.83160.4222.32K
P/B Ratio
-78.17-349.228.321.565.27K
PTB ratio
-78.17-349.228.321.565.27K
EV to sales
37.7422.68.450.144.12K
Enterprise value over EBITDA
-318.39-17.76-101.12-2.436.37K
EV to operating cash flow
-1.1K115.9120.163.4121.53K
EV to free cash flow
-988.69122.821.7121.9722.31K
Earnings yield
0-0.05-0.01-0.040
Free cash flow yield
00.010.040.010
Debt to equity
000.010.060.01
Debt to assets
000.010.030.01
Net debt to EBITDA
0.390.3819.2415.14-9.33
Current ratio
0.470.892.562.12.23
Interest coverage
060.94.333.18-5.27
Income quality
0.26-0.15-5.95-1.031.72
Dividend Yield
000.0100
Payout ratio
-0.62-0.01-1.7600
Sales general and administrative to revenue
0.110.870.220.10.11
Research and developement to revenue
0.40.780.380.440.32
Intangibles to total assets
000.010.020.02
Capex to operating cash flow
0.12-0.06-0.07-0.84-0.03
Capex to revenue
0-0.01-0.03-0.03-0.01
Capex to depreciation
-1.45-4.01-5.65-5.03-0.61
Stock based compensation to revenue
01.240.150.020.01
Graham number
3.516.6116.2613.350.01
ROIC
-0.735.410.060.08-0.12
Return on tangible assets
-0.3-1.64-0.04-0.030.08
Graham Net
-2.01-1.1411.597.90
Working capital
-65.01M-19.7M622.24M532.31M692.74M
Tangible asset value
-63.87M-14.55M630.86M581.08M744.58M
Net current asset value
-65.01M-19.7M617.17M522.73M689.84M
Invested capital
000.010.060.01
Average receivables
017.3M49.64M68.63M70.44M
Average payables
011.72M15.93M26.04M27.37M
Average inventory
025.15M18.77M22.46M23.59M
Days sales outstanding
37.7135.0353.7222.7930.33
Days payables outstanding
72.844.6847.2539.2330.02
Days of inventory on hand
164.2289.623736.0423.72
Receivables turnover
9.6810.426.7916.0212.03
Payables turnover
5.018.177.729.312.16
Inventory turnover
2.224.079.8710.1315.39
ROE
0.2819.07-0.06-0.060.14
Capex per share
-0.01-0.05-0.35-0.610

Quarterly Fundamentals Overview

Last date of statement is 2022-12-31 for Q4

Metric History 2021-12-312022-03-312022-06-302022-09-30 2022-12-31
Revenue per share
4.464.544.334.724.9
Net income per share
-0.150.250.410.740.67
Operating cash flow per share
00003.56
Free cash flow per share
00003.52
Cash per share
16.0414.8516.0617.8419.73
Book value per share
11.4111.5612.5413.8914.46
Tangible book value per share
11.4111.5612.5413.8913.99
Share holders equity per share
11.4111.5612.5413.8914.46
Interest debt per share
0.590.470.280.080.07
Market cap
951.54M728.06M842.92M834.42M954.11M
Enterprise value
130.43M38.58M152.34M-30.5M-86.87M
P/E ratio
-30.0813.889.675.286.73
Price to sales ratio
433.663.323.66
POCF ratio
00005.03
PFCF ratio
00005.1
P/B Ratio
1.561.181.261.131.24
PTB ratio
1.561.181.261.131.24
EV to sales
0.550.160.66-0.12-0.33
Enterprise value over EBITDA
-16.543.426.74-0.79-2.22
EV to operating cash flow
0000-0.46
EV to free cash flow
0000-0.46
Earnings yield
-0.010.020.030.050.04
Free cash flow yield
00000.2
Debt to equity
0.060.050.030.020.01
Debt to assets
0.030.030.020.010.01
Net debt to EBITDA
104.15-61.05-30.54-22.44-26.6
Current ratio
2.12.12.272.372.23
Interest coverage
3.93-2.37-7.75-3.01-10.35
Income quality
00001.97
Dividend Yield
00000
Payout ratio
00000.08
Sales general and administrative to revenue
0.130.110.130.10.11
Research and developement to revenue
0.460.40.340.290.26
Intangibles to total assets
00.030.030.020.02
Capex to operating cash flow
0000-0.01
Capex to revenue
0000-0.01
Capex to depreciation
0000-0.24
Stock based compensation to revenue
00000.05
Graham number
6.177.9910.7415.2214.72
ROIC
0.02-0.02-0.06-0.04-0.06
Return on tangible assets
-0.010.010.020.030.03
Graham Net
7.97.468.6410.0110.47
Working capital
532.31M517.53M581.65M658.16M692.74M
Tangible asset value
608.37M590.74M640.34M712.52M744.58M
Net current asset value
522.73M513.74M578.16M654.96M689.84M
Invested capital
0.060.050.030.020.01
Average receivables
68.2M75.2M80.98M75.47M81.15M
Average payables
33.7M27.67M22.17M16.72M19.06M
Average inventory
26.45M26.2M24.26M20.34M17.82M
Days sales outstanding
22.3233.9127.5328.7728.27
Days payables outstanding
37.6930.6726.0716.8227.33
Days of inventory on hand
34.6330.132.2619.9821.6
Receivables turnover
4.032.653.273.133.18
Payables turnover
2.392.933.455.353.29
Inventory turnover
2.62.992.794.54.17
ROE
-0.010.020.030.050.05
Capex per share
0000-0.05

IH Frequently Asked Questions

What is iHuman Inc. stock symbol ?

iHuman Inc. is a CN stock and trading under the symbol IH

What is iHuman Inc. stock quote today ?

iHuman Inc. stock price is $2.96 today.

Is iHuman Inc. stock public?

Yes, iHuman Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap